PRP — IND submission
Q4 2026
We have commenced our study preparation process with the contract research organization ("CRO"), analytical lab and trial site(s) selection and begun our clinical trial application for PRP ("CTA") compilation and plan to submit the CTA in the fourth quarter of the 2026 calendar year.Source filing